Kura Oncology’s Chief Legal Officer Tries to Sell, but Pre‑planned Trades Hint at Calm, Not Panic.
Insider sales by Kura Oncology’s execs, including a May 18 sale, reveal a balanced buying‑selling strategy rather than panic, highlighting the need to focus on clinical milestones for future value.
3 minutes to read